{"filepath": "../L2M3_data/1_application_papers/acs_xml/ja0c06143.xml", "publisher": "acs", "elements": [{"idx": 1, "type": "text", "classification": ["else"], "content": "<p>Amyloidogenic\npeptides and proteins are rich sources of supramolecular assemblies.\nSequences derived from well-known amyloids, including A\u03b2, human\nislet amyloid polypeptide, and tau have been found to assemble as\nfibrils, nanosheets, ribbons, and nanotubes. The supramolecular assembly\nof medin, a 50-amino acid peptide that forms fibrillary deposits in\naging human vasculature, has not been heavily investigated. In this\nwork, we present an X-ray crystallographic structure of a cyclic \u03b2-sheet\npeptide derived from the 19\u201336 region of medin that assembles\nto form interpenetrating cubes. The edge of each cube is composed\nof a single peptide, and each vertex is occupied by a divalent metal\nion. This structure may be considered a metal\u2013organic framework\n(MOF) containing a large peptide ligand. This work demonstrates that\npeptides containing Glu or Asp that are preorganized to adopt \u03b2-hairpin\nstructures can serve as ligands and assemble with metal ions to form\nMOFs.</p>", "clean_text": "Amyloidogenic peptides and proteins are rich sources of supramolecular assemblies. Sequences derived from well-known amyloids, including A\u03b2, human islet amyloid polypeptide, and tau have been found to assemble as fibrils, nanosheets, ribbons, and nanotubes. The supramolecular assembly of medin, a 50-amino acid peptide that forms fibrillary deposits in aging human vasculature, has not been heavily investigated. In this work, we present an X-ray crystallographic structure of a cyclic \u03b2-sheet peptide derived from the 19-36 region of medin that assembles to form interpenetrating cubes. The edge of each cube is composed of a single peptide, and each vertex is occupied by a divalent metal ion. This structure may be considered a metal-organic framework (MOF) containing a large peptide ligand. This work demonstrates that peptides containing Glu or Asp that are preorganized to adopt \u03b2-hairpin structures can serve as ligands and assemble with metal ions to form MOFs.", "data": null, "include_properties": null}, {"idx": 2, "type": "text", "classification": ["else"], "content": "<title>Introduction</title><p>Amyloidogenic peptides\nand proteins are rich sources of supramolecular assemblies. Sequences\nderived from A\u03b2 (Alzheimer\u2019s disease), human islet amyloid\npolypeptide (type II diabetes), and tau (Alzheimer\u2019s disease\nand frontotemporal dementia) have been found to assemble as fibrils,\nnanosheets, ribbons, and nanotubes (). Other types of assemblies have also been observed, including square\nchannels from sequences derived from transthyretin (senile systemic\namyloidosis) and cylindrins from sequences derived from \u03b1B-Crystallin\n(cataracts). Although these well characterized\namyloidogenic peptides and proteins have yielded many novel supramolecular\nassemblies, the more recently discovered amyloidogenic peptide medin\nhas not been as heavily studied and provides an exciting frontier\nfor the discovery of interesting supramolecular assemblies.</p>", "clean_text": "Introduction\n\nAmyloidogenic peptides and proteins are rich sources of supramolecular assemblies. Sequences derived from A\u03b2 (Alzheimer's disease), human islet amyloid polypeptide (type II diabetes), and tau (Alzheimer's disease and frontotemporal dementia) have been found to assemble as fibrils, nanosheets, ribbons, and nanotubes (). Other types of assemblies have also been observed, including square channels from sequences derived from transthyretin (senile systemic amyloidosis) and cylindrins from sequences derived from \u03b1B-Crystallin (cataracts). Although these well characterized amyloidogenic peptides and proteins have yielded many novel supramolecular assemblies, the more recently discovered amyloidogenic peptide medin has not been as heavily studied and provides an exciting frontier for the discovery of interesting supramolecular assemblies.", "data": null, "include_properties": null}, {"idx": 3, "type": "table", "classification": null, "content": "<table-wrap id=\"tbl1\" position=\"float\">\n<label>1</label>\n<caption>\n<title>Supramolecular Assemblies of Selected Sequences Derived\nfrom Amyloidogenic Peptides and Proteins</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"4\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col4\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\">peptide</oasis:entry>\n<oasis:entry align=\"center\">sequence</oasis:entry>\n<oasis:entry align=\"center\">assembly</oasis:entry>\n<oasis:entry align=\"center\">citation</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>A\u03b2(10\u201335)</oasis:entry>\n<oasis:entry>YEV\u00adHHQ\u00adKLV\u00adFFA\u00adEDV\u00adGSN\u00adKGA\u00adIIG\u00adLM</oasis:entry>\n<oasis:entry>fibril<xref ref-type=\"table-fn\" rid=\"t1fn1\"></xref>\n<sup>,</sup>\n<xref ref-type=\"table-fn\" rid=\"t1fn2\"></xref>\n</oasis:entry>\n<oasis:entry>\n<named-content content-type=\"bibref-group\">\n<xref ref-type=\"bibr\" rid=\"ref1\" specific-use=\"ref-style=base-text\"></xref>\u2212<xref ref-type=\"bibr\" rid=\"ref2\" specific-use=\"suppress-in-print\"></xref>\n<xref ref-type=\"bibr\" rid=\"ref3\" specific-use=\"ref-style=base-text\"></xref>\n</named-content>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>A\u03b2(16\u201322)</oasis:entry>\n<oasis:entry>Ac-KLVFFAE-NH2</oasis:entry>\n<oasis:entry>fibril, helical ribbon, nanotube<xref ref-type=\"table-fn\" rid=\"t1fn1\"></xref>\n<sup>,</sup>\n<xref ref-type=\"table-fn\" rid=\"t1fn2\"></xref>\n<sup>,</sup>\n<xref ref-type=\"table-fn\" rid=\"t1fn3\"></xref>\n<sup>,</sup>\n<xref ref-type=\"table-fn\" rid=\"t1fn4\"></xref>\n</oasis:entry>\n<oasis:entry>\n<named-content content-type=\"bibref-group\">\n<xref ref-type=\"bibr\" rid=\"ref4\" specific-use=\"ref-style=base-text\"></xref>\u2212<xref ref-type=\"bibr\" rid=\"ref5\" specific-use=\"suppress-in-print\"></xref>\n<xref ref-type=\"bibr\" rid=\"ref6\" specific-use=\"ref-style=base-text\"></xref>\n</named-content>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry></oasis:entry>\n<oasis:entry>KLVF(<italic>N</italic>-Me)FAE,\nKLVFFAE</oasis:entry>\n<oasis:entry>nanotube<xref ref-type=\"table-fn\" rid=\"t1fn5\"></xref>\n</oasis:entry>\n<oasis:entry>\n<xref ref-type=\"bibr\" rid=\"ref7\" specific-use=\"ref-style=base-text\"></xref>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>A\u03b2(16\u201322), Italian mutant</oasis:entry>\n<oasis:entry>KLVFFAK</oasis:entry>\n<oasis:entry>nanosheet<xref ref-type=\"table-fn\" rid=\"t1fn2\"></xref>\n<sup>,</sup>\n<xref ref-type=\"table-fn\" rid=\"t1fn3\"></xref>\n</oasis:entry>\n<oasis:entry>\n<xref ref-type=\"bibr\" rid=\"ref8\" specific-use=\"ref-style=base-text\"></xref>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry morerows=\"1\">A\u03b2(16\u201320)</oasis:entry>\n<oasis:entry>AAKLVFF</oasis:entry>\n<oasis:entry>nanotube<xref ref-type=\"table-fn\" rid=\"t1fn2\"></xref>\n</oasis:entry>\n<oasis:entry>\n<named-content content-type=\"bibref-group\">\n<xref ref-type=\"bibr\" rid=\"ref9\" specific-use=\"ref-style=base-text\"></xref>,<xref ref-type=\"bibr\" rid=\"ref10\" specific-use=\"ref-style=base-text\"></xref>\n</named-content>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b2A\u03b2AKLVFF</oasis:entry>\n<oasis:entry>helical ribbon<xref ref-type=\"table-fn\" rid=\"t1fn4\"></xref>\n</oasis:entry>\n<oasis:entry>\n<xref ref-type=\"bibr\" rid=\"ref11\" specific-use=\"ref-style=base-text\"></xref>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>A\u03b2(19\u201320)</oasis:entry>\n<oasis:entry>FF</oasis:entry>\n<oasis:entry>nanotube<xref ref-type=\"table-fn\" rid=\"t1fn2\"></xref>\n</oasis:entry>\n<oasis:entry>\n<xref ref-type=\"bibr\" rid=\"ref12\" specific-use=\"ref-style=base-text\"></xref>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry></oasis:entry>\n<oasis:entry>Ac-FF-NH<sub>2</sub>, NH<sub>2</sub>-FF-NH<sub>2</sub>, Boc-FF-NH2</oasis:entry>\n<oasis:entry>nanotube<xref ref-type=\"table-fn\" rid=\"t1fn2\"></xref>\n<sup>,</sup>\n<xref ref-type=\"table-fn\" rid=\"t1fn3\"></xref>\n</oasis:entry>\n<oasis:entry>\n<xref ref-type=\"bibr\" rid=\"ref13\" specific-use=\"ref-style=base-text\"></xref>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry></oasis:entry>\n<oasis:entry>Fmoc-FF</oasis:entry>\n<oasis:entry>flat ribbon, fibril<xref ref-type=\"table-fn\" rid=\"t1fn2\"></xref>\n<sup>,</sup>\n<xref ref-type=\"table-fn\" rid=\"t1fn3\"></xref>\n<sup>,</sup>\n<xref ref-type=\"table-fn\" rid=\"t1fn4\"></xref>\n</oasis:entry>\n<oasis:entry>\n<named-content content-type=\"bibref-group\">\n<xref ref-type=\"bibr\" rid=\"ref13\" specific-use=\"ref-style=base-text\"></xref>,<xref ref-type=\"bibr\" rid=\"ref14\" specific-use=\"ref-style=base-text\"></xref>\n</named-content>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>hIAPP(20\u201329)</oasis:entry>\n<oasis:entry>SNNFGAILSS</oasis:entry>\n<oasis:entry>flat ribbon, helical ribbon<xref ref-type=\"table-fn\" rid=\"t1fn3\"></xref>\n<sup>,</sup>\n<xref ref-type=\"table-fn\" rid=\"t1fn4\"></xref>\n</oasis:entry>\n<oasis:entry>\n<xref ref-type=\"bibr\" rid=\"ref15\" specific-use=\"ref-style=base-text\"></xref>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry></oasis:entry>\n<oasis:entry>SNNFG(<italic>N</italic>-Bu)AI(<italic>N</italic>-Bu)LS(<italic>N</italic>-Bu)S</oasis:entry>\n<oasis:entry>helical ribbon<xref ref-type=\"table-fn\" rid=\"t1fn2\"></xref>\n</oasis:entry>\n<oasis:entry>\n<xref ref-type=\"bibr\" rid=\"ref16\" specific-use=\"ref-style=base-text\"></xref>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>hIAPP(21\u201329)</oasis:entry>\n<oasis:entry>NNFGAILSS</oasis:entry>\n<oasis:entry>helical ribbon<xref ref-type=\"table-fn\" rid=\"t1fn2\"></xref>\n<sup>,</sup>\n<xref ref-type=\"table-fn\" rid=\"t1fn3\"></xref>\n</oasis:entry>\n<oasis:entry>\n<xref ref-type=\"bibr\" rid=\"ref17\" specific-use=\"ref-style=base-text\"></xref>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>hIAPP(23\u201327)</oasis:entry>\n<oasis:entry>FGAIL</oasis:entry>\n<oasis:entry>flat ribbon<xref ref-type=\"table-fn\" rid=\"t1fn2\"></xref>\n<sup>,</sup>\n<xref ref-type=\"table-fn\" rid=\"t1fn3\"></xref>\n</oasis:entry>\n<oasis:entry>\n<xref ref-type=\"bibr\" rid=\"ref18\" specific-use=\"ref-style=base-text\"></xref>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>tau(306-311)</oasis:entry>\n<oasis:entry>Ac-VQIVYK-NH<sub>2</sub>\n</oasis:entry>\n<oasis:entry>straight and twisted\nfilament<xref ref-type=\"table-fn\" rid=\"t1fn2\"></xref>\n</oasis:entry>\n<oasis:entry>\n<xref ref-type=\"bibr\" rid=\"ref19\" specific-use=\"ref-style=base-text\"></xref>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>transthyretin(106\u2013112, 115\u2013121)</oasis:entry>\n<oasis:entry>TIAA(<italic>N</italic>-Me)LLS, SFSTTAV</oasis:entry>\n<oasis:entry>square channel<xref ref-type=\"table-fn\" rid=\"t1fn5\"></xref>\n</oasis:entry>\n<oasis:entry>\n<xref ref-type=\"bibr\" rid=\"ref20\" specific-use=\"ref-style=base-text\"></xref>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b1B-crystallin(90\u2013100)</oasis:entry>\n<oasis:entry>KVK\u00adVLG\u00adDVI\u00adEV</oasis:entry>\n<oasis:entry>cylindrin<xref ref-type=\"table-fn\" rid=\"t1fn2\"></xref>\n<sup>,</sup>\n<xref ref-type=\"table-fn\" rid=\"t1fn5\"></xref>\n</oasis:entry>\n<oasis:entry>\n<xref ref-type=\"bibr\" rid=\"ref21\" specific-use=\"ref-style=base-text\"></xref>\n</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n<table-wrap-foot>\n<fn id=\"t1fn1\">\n<label>a</label>\n<p>Solid-state NMR (ssNMR).</p>\n</fn>\n<fn id=\"t1fn2\">\n<label>b</label>\n<p>Electron microscopy (EM).</p>\n</fn>\n<fn id=\"t1fn3\">\n<label>c</label>\n<p>Atomic force microscopy (AFM).</p>\n</fn>\n<fn id=\"t1fn4\">\n<label>d</label>\n<p>Cryo-EM.</p>\n</fn>\n<fn id=\"t1fn5\">\n<label>e</label>\n<p>X-ray crystallography.</p>\n</fn>\n</table-wrap-foot>\n</table-wrap>", "clean_text": "", "data": null, "include_properties": null}, {"idx": 4, "type": "text", "classification": ["else"], "content": "<p>Medin, also referred to as aortic medial amyloid, is a 50-amino acid\npeptide that forms fibrillary deposits in aging human vasculature\n(). These deposits have been implicated in the pathogenesis\nof thoracic aortic aneurysm and dissection. Westermark et al. found\nevidence of fibrillary medin in the aortic media of 97% of subjects\nover the age of 50. Although the amino\nacid sequence of medin was determined in 1999, the folding pattern\nof the monomer was not elucidated until 2017. Using <sup>13</sup>C NMR spectroscopy, Madine et al. identified\nthat the monomer of medin contains three \u03b2-strand regions consisting\nof residues 7\u201313, 21\u201325, and 30\u201336. The sequences 14\u201324 and 26\u201329\nwere suggested to form unstructured loops. Computational modeling\nusing QUARK and ROSETTA consistently predicted the 21\u201335 region\nto fold as a \u03b2-hairpin.\n</p>", "clean_text": "Medin, also referred to as aortic medial amyloid, is a 50-amino acid peptide that forms fibrillary deposits in aging human vasculature (). These deposits have been implicated in the pathogenesis of thoracic aortic aneurysm and dissection. Westermark et al. found evidence of fibrillary medin in the aortic media of 97% of subjects over the age of 50. Although the amino acid sequence of medin was determined in 1999, the folding pattern of the monomer was not elucidated until 2017. Using 13C NMR spectroscopy, Madine et al. identified that the monomer of medin contains three \u03b2-strand regions consisting of residues 7-13, 21-25, and 30-36. The sequences 14-24 and 26-29 were suggested to form unstructured loops. Computational modeling using QUARK and ROSETTA consistently predicted the 21-35 region to fold as a \u03b2-hairpin. ", "data": null, "include_properties": null}, {"idx": 5, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig1\" position=\"float\">\n<label>1</label>\n<caption>\n<p>Amino acid\nsequence of medin. Amyloidogenic regions predicted by TANGO are highlighted\nin red. Underlined residues are \u03b2-strand regions identified\nby <sup>13</sup>C NMR spectroscopy.</p>\n</caption>\n<graphic id=\"gr1\" position=\"float\" xlink:href=\"ja0c06143_0001.tif\"></graphic>\n</fig>", "clean_text": " 1  Amino acid sequence of medin. Amyloidogenic regions predicted by TANGO are highlighted in red. Underlined residues are \u03b2-strand regions identified by 13C NMR spectroscopy.   ", "data": null, "include_properties": null}, {"idx": 6, "type": "text", "classification": ["else"], "content": "<p>Medin is predicted by TANGO to have three amyloidogenic regions (). Westermark et al. studied the medin(1\u201325), medin(32\u201341),\nand medin(42\u201349) peptides. The researchers only observed the\nformation of fibrils from the latter two peptides by electron microscopy\nand concluded that the amyloid forming motif of medin lies in its\nC-terminus. Gazit et al. also observed the formation of fibrils by\nthe medin(42\u201349) peptide by electron microscopy. Middleton et al. subsequently used solid-state\nNMR spectroscopy and X-ray fiber diffraction to establish that the\nfibrils from medin(42\u201349) consist of parallel, in-register\n\u03b2-sheets that assemble in a face-to-back manner. To our knowledge, no additional structural information\nregarding the assembly of medin(32\u201341) has been elucidated.</p>", "clean_text": "Medin is predicted by TANGO to have three amyloidogenic regions (). Westermark et al. studied the medin(1-25), medin(32-41), and medin(42-49) peptides. The researchers only observed the formation of fibrils from the latter two peptides by electron microscopy and concluded that the amyloid forming motif of medin lies in its C-terminus. Gazit et al. also observed the formation of fibrils by the medin(42-49) peptide by electron microscopy. Middleton et al. subsequently used solid-state NMR spectroscopy and X-ray fiber diffraction to establish that the fibrils from medin(42-49) consist of parallel, in-register \u03b2-sheets that assemble in a face-to-back manner. To our knowledge, no additional structural information regarding the assembly of medin(32-41) has been elucidated.", "data": null, "include_properties": null}, {"idx": 7, "type": "text", "classification": ["else"], "content": "<title>Results</title><p>To gain further insights into the supramolecular assembly of medin,\nwe set out to study the two \u03b2-strand regions in the medin monomer\npredicted to fold as a \u03b2-hairpin. To synthesize the \u03b2-hairpin\nmimic peptide <bold>1</bold>, we connected two heptapeptide strands\nusing \u03b4-linked ornithine (<sup>\u03b4</sup>Orn) turn units\n(blue) to form a macrocycle. The two heptapeptide\nstrands are derived from medin(19\u201325) DQWLQVD (top strand)\nand medin(31\u201337) EVTGIIT (bottom strand). <italic>N</italic>-Methylation (red) of the backbone was employed to attenuate uncontrolled\naggregation. This strategy to make \u03b2-hairpin\nmimics has been successfully used by our lab in the past to identify\nother amyloid assemblies using X-ray crystallography.\n<graphic id=\"gr2\" position=\"float\" xlink:href=\"ja0c06143_0006.tif\"></graphic>\n</p>", "clean_text": "Results\n\nTo gain further insights into the supramolecular assembly of medin, we set out to study the two \u03b2-strand regions in the medin monomer predicted to fold as a \u03b2-hairpin. To synthesize the \u03b2-hairpin mimic peptide 1, we connected two heptapeptide strands using \u03b4-linked ornithine (\u03b4Orn) turn units (blue) to form a macrocycle. The two heptapeptide strands are derived from medin(19-25) DQWLQVD (top strand) and medin(31-37) EVTGIIT (bottom strand). N-Methylation (red) of the backbone was employed to attenuate uncontrolled aggregation. This strategy to make \u03b2-hairpin mimics has been successfully used by our lab in the past to identify other amyloid assemblies using X-ray crystallography.  ", "data": null, "include_properties": null}, {"idx": 8, "type": "text", "classification": ["synthesis condition"], "content": "<p>We used X-ray crystallography to study the structure\nand assembly of peptide <bold>1</bold>. We began our crystallization\nefforts by screening peptide <bold>1</bold> in 576 conditions in a\n96-well plate format using crystallization kits from Hampton Research.\nCube-shaped crystals () grew in\nabundance in drops containing sodium acetate, calcium chloride, and\n2-methyl-2,4-pentanediol. Further optimization of the crystallization\nconditions afforded monocrystals suitable for X-ray diffraction (optimized\nconditions: 0.1 M NaOAc, 0.02 M CaCl<sub>2</sub>, 30% MPD). The X-ray\ndiffraction experiments were performed at 1.54 \u00c5 using an X-ray\ndiffractometer. Despite the relatively high resolution of the acquired\ndata set (ca. 1.32 \u00c5), we were unable to solve the structure\nby single wavelength anomalous diffraction (SAD). In an attempt to\nincrease the magnitude of anomalous scattering, we crystallized peptide <bold>1</bold> in the optimized conditions substituting barium chloride\nfor calcium chloride. The modified conditions afforded similar cube-shaped\ncrystals that gave rise to enough measurable anomalous signal to facilitate\nSAD phasing and subsequent solution of the original data set by isomorphous\nreplacement. The structure was thus solved in the cubic <italic>I</italic>23 space group and refined to a final R<sub>work</sub> of 0.1772\n(PDB <ext-link ext-link-type=\"pdb\" xlink:href=\"7JRH\">7JRH</ext-link>).</p>", "clean_text": "We used X-ray crystallography to study the structure and assembly of peptide 1. We began our crystallization efforts by screening peptide 1 in 576 conditions in a 96-well plate format using crystallization kits from Hampton Research. Cube-shaped crystals () grew in abundance in drops containing sodium acetate, calcium chloride, and 2-methyl-2,4-pentanediol. Further optimization of the crystallization conditions afforded monocrystals suitable for X-ray diffraction (optimized conditions: 0.1 M NaOAc, 0.02 M CaCl2, 30% MPD). The X-ray diffraction experiments were performed at 1.54 \u00c5 using an X-ray diffractometer. Despite the relatively high resolution of the acquired data set (ca. 1.32 \u00c5), we were unable to solve the structure by single wavelength anomalous diffraction (SAD). In an attempt to increase the magnitude of anomalous scattering, we crystallized peptide 1 in the optimized conditions substituting barium chloride for calcium chloride. The modified conditions afforded similar cube-shaped crystals that gave rise to enough measurable anomalous signal to facilitate SAD phasing and subsequent solution of the original data set by isomorphous replacement. The structure was thus solved in the cubic I23 space group and refined to a final Rwork of 0.1772 (PDB 7JRH).", "data": null, "include_properties": null}, {"idx": 9, "type": "text", "classification": ["else"], "content": "<p>The X-ray crystallographic structure of peptide <bold>1</bold> reveals\na three-dimensional network of large interpenetrating cubes, ca. 4.3\nnm in size (). Each cube is composed of molecules of peptide <bold>1</bold> located\nat the edges and coordinated to calcium ions at the vertices. In the\nstructure, peptide <bold>1</bold> folds to form a hydrogen-bonded\n\u03b2-sheet. The elongated \u03b2-strand conformation of the top\nstrand places the two aspartic acid residues (D<sub>19</sub> and D<sub>25</sub>) at the opposite ends of the \u03b2-sheet, ca. 2.0 nm apart.\nThe side chain carboxylate group of D<sub>19</sub> binds one calcium\nion, and the side chain of D<sub>25</sub> binds another calcium ion.\nEach of the ions in turn binds either D<sub>19</sub> or D<sub>25</sub> residues of two other peptide molecules. This mode of coordination,\nin conjunction with the symmetry present in the crystal lattice, results\nin the formation of an assembly containing eight calcium ions and\n12 molecules of peptide <bold>1</bold>. Even though the arrangement\nof edges and vertices resembles a cube (A,B), the point symmetry is actually tetrahedral,\nwith four of the vertices arising from the coordination of D<sub>19</sub> and the other four vertices arising from the coordination of D<sub>25</sub>.</p>", "clean_text": "The X-ray crystallographic structure of peptide 1 reveals a three-dimensional network of large interpenetrating cubes, ca. 4.3 nm in size (). Each cube is composed of molecules of peptide 1 located at the edges and coordinated to calcium ions at the vertices. In the structure, peptide 1 folds to form a hydrogen-bonded \u03b2-sheet. The elongated \u03b2-strand conformation of the top strand places the two aspartic acid residues (D19 and D25) at the opposite ends of the \u03b2-sheet, ca. 2.0 nm apart. The side chain carboxylate group of D19 binds one calcium ion, and the side chain of D25 binds another calcium ion. Each of the ions in turn binds either D19 or D25 residues of two other peptide molecules. This mode of coordination, in conjunction with the symmetry present in the crystal lattice, results in the formation of an assembly containing eight calcium ions and 12 molecules of peptide 1. Even though the arrangement of edges and vertices resembles a cube (A,B), the point symmetry is actually tetrahedral, with four of the vertices arising from the coordination of D19 and the other four vertices arising from the coordination of D25.", "data": null, "include_properties": null}, {"idx": 10, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig2\" position=\"float\">\n<label>2</label>\n<caption>\n<p>Three-dimensional assembly observed in the X-ray crystallographic\nstructure of peptide <bold>1</bold>. Individual cube (A), infinite\narray of cubes (C), and two interpenetrating arrays (E), along with\ntheir respective schematic representations (B, D, and F). The cubes\nare all symmetry-equivalent, and the coloring scheme has been chosen\narbitrarily for clarity.</p>\n</caption>\n<graphic id=\"gr3\" position=\"float\" xlink:href=\"ja0c06143_0002.tif\"></graphic>\n</fig>", "clean_text": " 2  Three-dimensional assembly observed in the X-ray crystallographic structure of peptide 1. Individual cube (A), infinite array of cubes (C), and two interpenetrating arrays (E), along with their respective schematic representations (B, D, and F). The cubes are all symmetry-equivalent, and the coloring scheme has been chosen arbitrarily for clarity.   ", "data": null, "include_properties": null}, {"idx": 11, "type": "text", "classification": ["else"], "content": "<p>The cubes stack face-to-face\nin the crystal lattice in all three directions, forming an infinite\n3-dimensional array (C,D). Consistent with the body-centered lattice type, the\ncomplete crystal lattice contains two symmetry-equivalent mutually\ninterpenetrating arrays, related through a [0.5, 0.5, 0.5] Bravais\ntranslation vector (E,F). Such a polycatenated structure\nbelongs to the <bold>bcu-y</bold> class in knot theory, a 3D \u201cchainmail\u201d\nof linked cubes.\n</p>", "clean_text": "The cubes stack face-to-face in the crystal lattice in all three directions, forming an infinite 3-dimensional array (C,D). Consistent with the body-centered lattice type, the complete crystal lattice contains two symmetry-equivalent mutually interpenetrating arrays, related through a [0.5, 0.5, 0.5] Bravais translation vector (E,F). Such a polycatenated structure belongs to the bcu-y class in knot theory, a 3D \"chainmail\" of linked cubes. ", "data": null, "include_properties": null}, {"idx": 12, "type": "text", "classification": ["else"], "content": "<p>The packing of\nthe cubes, as shown in C,D, is stabilized by hydrogen bonding and hydrophobic interactions\nbetween molecules of peptide <bold>1</bold> located at the edges of\nthe cubes. The four molecules of peptide <bold>1</bold> that constitute\nthe edges of every four adjacent cubes form a tetramer (A). The tetramer can be interpreted\nas a dimer of dimers, in which each dimer is stabilized by six intermolecular\nhydrogen bonds involving side chains and main chains of T<sub>37</sub>, Q<sub>23</sub>, and I<sub>35</sub> (B). The dimers stack to form the tetramer.\nPacking of the hydrophobic side chains of I<sub>35</sub>, V<sub>32</sub>, and L<sub>22</sub>, a total of 12 residues, three per monomer,\nhelp stabilize the tetramer. Eight hydrogen bonds between Q<sub>20</sub> and V<sub>32</sub> further stabilize the assembly.</p>", "clean_text": "The packing of the cubes, as shown in C,D, is stabilized by hydrogen bonding and hydrophobic interactions between molecules of peptide 1 located at the edges of the cubes. The four molecules of peptide 1 that constitute the edges of every four adjacent cubes form a tetramer (A). The tetramer can be interpreted as a dimer of dimers, in which each dimer is stabilized by six intermolecular hydrogen bonds involving side chains and main chains of T37, Q23, and I35 (B). The dimers stack to form the tetramer. Packing of the hydrophobic side chains of I35, V32, and L22, a total of 12 residues, three per monomer, help stabilize the tetramer. Eight hydrogen bonds between Q20 and V32 further stabilize the assembly.", "data": null, "include_properties": null}, {"idx": 13, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig3\" position=\"float\">\n<label>3</label>\n<caption>\n<p>(A) The location of a\ntetramer within the cubic assembly of peptide <bold>1</bold>. (B)\nHydrogen-bonded dimer within the tetramer.</p>\n</caption>\n<graphic id=\"gr4\" position=\"float\" xlink:href=\"ja0c06143_0003.tif\"></graphic>\n</fig>", "clean_text": " 3  (A) The location of a tetramer within the cubic assembly of peptide 1. (B) Hydrogen-bonded dimer within the tetramer.   ", "data": null, "include_properties": null}, {"idx": 14, "type": "text", "classification": ["else"], "content": "<p>The monomeric \u03b2-hairpins that constitute the building blocks\nof the crystal lattice have an unexpected folding pattern. Peptide <bold>1</bold> was designed to contain two hydrogen-bonded \u03b2-strands,\nDQWLQVD (top strand) and EVTGIIT (bottom strand), linked by two <sup>\u03b4</sup>Orn turn units. In the X-ray crystallographic structure,\nthe top and bottom strands do indeed form a hydrogen-bonded \u03b2-sheet\nbut not precisely as designed (). Residues T<sub>33</sub> and G<sub>34</sub> in the\nbottom strand form a \u03b2-bulge, and\nsix of the seven residues of the top strand (Q<sub>20</sub> through\nD<sub>25</sub>) participate in \u03b2-sheet formation. The \u03b2-bulge\ncauses a shift in the registration of the strands, which brings D<sub>19</sub> into an extended loop with <sup>\u03b4</sup>Orn and causes\nT<sub>37</sub> to pair with Q<sub>20</sub> instead of D<sub>19</sub> (B).</p>", "clean_text": "The monomeric \u03b2-hairpins that constitute the building blocks of the crystal lattice have an unexpected folding pattern. Peptide 1 was designed to contain two hydrogen-bonded \u03b2-strands, DQWLQVD (top strand) and EVTGIIT (bottom strand), linked by two \u03b4Orn turn units. In the X-ray crystallographic structure, the top and bottom strands do indeed form a hydrogen-bonded \u03b2-sheet but not precisely as designed (). Residues T33 and G34 in the bottom strand form a \u03b2-bulge, and six of the seven residues of the top strand (Q20 through D25) participate in \u03b2-sheet formation. The \u03b2-bulge causes a shift in the registration of the strands, which brings D19 into an extended loop with \u03b4Orn and causes T37 to pair with Q20 instead of D19 (B).", "data": null, "include_properties": null}, {"idx": 15, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig4\" position=\"float\">\n<label>4</label>\n<caption>\n<p>\u03b2-Bulge\nin the X-ray crystallographic structure of peptide <bold>1</bold>.\n(A) X-ray crystallographic structure of the monomeric \u03b2-hairpin\nsubunit of the crystal lattice. (B) Hydrogen bonding pattern observed\nin the X-ray structure.</p>\n</caption>\n<graphic id=\"gr5\" position=\"float\" xlink:href=\"ja0c06143_0004.tif\"></graphic>\n</fig>", "clean_text": " 4  \u03b2-Bulge in the X-ray crystallographic structure of peptide 1. (A) X-ray crystallographic structure of the monomeric \u03b2-hairpin subunit of the crystal lattice. (B) Hydrogen bonding pattern observed in the X-ray structure.   ", "data": null, "include_properties": null}, {"idx": 16, "type": "text", "classification": ["else"], "content": "<title>Discussion</title><p>Coordination\nof Ca<sup>2+</sup> by carboxylates in the peptide <bold>1</bold> structure\nis reminiscent of calcium binding in structures ranging from EF-hand\nproteins to metal\u2013organic frameworks (MOFs). The D<sub>25</sub>-calcium binding site of peptide <bold>1</bold> contains three aspartate\ncarboxylates and three water molecules in an octahedral arrangement\n(A), while\nthe D<sub>19</sub>-calcium binding contains three aspartate carboxylates\nand one water molecule (B). EF-hands are a class of calcium-binding proteins featuring\na helix\u2013loop\u2013helix motif, containing multiple carboxylates\nand other ligands that bind Ca<sup>2+</sup>. Calmodulin is a prominent\nexample of this class of calcium-binding proteins, employing three\naspartates to bind Ca<sup>2+</sup>, in a fashion similar to the binding\nmode within the peptide <bold>1</bold> cubes (binding of C). Only a handful of calcium-based metal\u2013organic frameworks\nhave been reported, including MOFs suitable for removal of heavy metals\nfrom water and slow release of pesticides, far fewer than the number of MOFs containing\ntransition metals. Calcium-based materials,\nsuch as alginate gels, are of interest for applications in the foodstuffs\nand medicines, where only nontoxic metals are permissible. We anticipate that calcium-based MOFs may also have potential applications\nin these areas.</p>", "clean_text": "Discussion\n\nCoordination of Ca2+ by carboxylates in the peptide 1 structure is reminiscent of calcium binding in structures ranging from EF-hand proteins to metal-organic frameworks (MOFs). The D25-calcium binding site of peptide 1 contains three aspartate carboxylates and three water molecules in an octahedral arrangement (A), while the D19-calcium binding contains three aspartate carboxylates and one water molecule (B). EF-hands are a class of calcium-binding proteins featuring a helix-loop-helix motif, containing multiple carboxylates and other ligands that bind Ca2+. Calmodulin is a prominent example of this class of calcium-binding proteins, employing three aspartates to bind Ca2+, in a fashion similar to the binding mode within the peptide 1 cubes (binding of C). Only a handful of calcium-based metal-organic frameworks have been reported, including MOFs suitable for removal of heavy metals from water and slow release of pesticides, far fewer than the number of MOFs containing transition metals. Calcium-based materials, such as alginate gels, are of interest for applications in the foodstuffs and medicines, where only nontoxic metals are permissible. We anticipate that calcium-based MOFs may also have potential applications in these areas.", "data": null, "include_properties": null}, {"idx": 17, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig5\" position=\"float\">\n<label>5</label>\n<caption>\n<p>(A and B) Calcium binding geometry observed in the X-ray\ncrystallographic structure of peptide <bold>1</bold>. (C) Calcium\nbinding site in the calmodulin protein (PDB <ext-link ext-link-type=\"pdb\" xlink:href=\"1CLL\">1CLL</ext-link>). Calcium ions are\nshown as yellow spheres and water molecules as red spheres.</p>\n</caption>\n<graphic id=\"gr6\" position=\"float\" xlink:href=\"ja0c06143_0005.tif\"></graphic>\n</fig>", "clean_text": " 5  (A and B) Calcium binding geometry observed in the X-ray crystallographic structure of peptide 1. (C) Calcium binding site in the calmodulin protein (PDB 1CLL). Calcium ions are shown as yellow spheres and water molecules as red spheres.   ", "data": null, "include_properties": null}, {"idx": 18, "type": "text", "classification": ["else"], "content": "<p>The noncovalent interactions in the crystal structure\nof peptide <bold>1</bold> are diverse: metal coordination, hydrogen\nbonding, and hydrophobic packing. Although it is not possible to assess\nthe relative contributions of each of these interactions in stabilizing\nthe assembly, metal coordination is critical. We have not observed\ngrowth of any stable crystals in the absence of divalent metal ions\n(Ca<sup>2+</sup>, Ba<sup>2+</sup>, or Co<sup>2+</sup>). The interpenetrating\ncubes formed by peptide <bold>1</bold> and Ca<sup>2+</sup> can thus\nbe considered a calcium-based MOF with peptide ligands and not merely\nan artificial calcium receptor.</p>", "clean_text": "The noncovalent interactions in the crystal structure of peptide 1 are diverse: metal coordination, hydrogen bonding, and hydrophobic packing. Although it is not possible to assess the relative contributions of each of these interactions in stabilizing the assembly, metal coordination is critical. We have not observed growth of any stable crystals in the absence of divalent metal ions (Ca2+, Ba2+, or Co2+). The interpenetrating cubes formed by peptide 1 and Ca2+ can thus be considered a calcium-based MOF with peptide ligands and not merely an artificial calcium receptor.", "data": null, "include_properties": null}, {"idx": 19, "type": "text", "classification": ["else"], "content": "<p>The interpenetrating cubes cannot\nform separately but rather must form simultaneously from tetramers,\ndimers, single molecules, or other assemblies of peptide <bold>1</bold> during the crystallization process. For this reason, the lattice\nmay also be interpreted as a result of the assembly of tetramers,\nwith the tetramers acting as ligands bearing eight carboxylate groups.\nRegardless of the process by which the lattice assembles, it can ultimately\nbe viewed as an assembly of cubes with Ca<sup>2+</sup> at the vertices,\nbecause of the crucial role metal cations play in the assembly.</p>", "clean_text": "The interpenetrating cubes cannot form separately but rather must form simultaneously from tetramers, dimers, single molecules, or other assemblies of peptide 1 during the crystallization process. For this reason, the lattice may also be interpreted as a result of the assembly of tetramers, with the tetramers acting as ligands bearing eight carboxylate groups. Regardless of the process by which the lattice assembles, it can ultimately be viewed as an assembly of cubes with Ca2+ at the vertices, because of the crucial role metal cations play in the assembly.", "data": null, "include_properties": null}, {"idx": 20, "type": "text", "classification": ["else"], "content": "<p>Intrinsic chirality and biocompatibility have allowed peptides to\nact as ligands in a number of MOFs possessing remarkable properties.\nThese structures include MOFs exhibiting selective binding of chiral\nmolecules, reversible conformational\nchanges upon binding, and high mechanical stability. The relative flexibility of peptide chains,\nwhich impart these interesting properties, is also a major limiting\nfactor. In longer peptide chains, it is almost impossible to predict\nand the control secondary structure. A notable example is a pentapeptide-cadmium\ncomplex reported by Yaghi et al. that exhibits no porosity. In the case of the framework structure formed\nby peptide <bold>1</bold>, the greatly reduced conformational flexibility\nof the cyclic \u03b2-sheet peptide is sufficient to allow the formation\nof a well-defined assembly. The preorganized spatial arrangement of\nthe two aspartate side chains allows the peptide to behave like a\nrigid ligand. Thus, a design principle emerges for the construction\nof other peptide-based MOFs, whereby a preference for a particular\nsecondary structure allows preorganization of metal-binding ligands\n(e.g., Glu, Asp, or His).</p>", "clean_text": "Intrinsic chirality and biocompatibility have allowed peptides to act as ligands in a number of MOFs possessing remarkable properties. These structures include MOFs exhibiting selective binding of chiral molecules, reversible conformational changes upon binding, and high mechanical stability. The relative flexibility of peptide chains, which impart these interesting properties, is also a major limiting factor. In longer peptide chains, it is almost impossible to predict and the control secondary structure. A notable example is a pentapeptide-cadmium complex reported by Yaghi et al. that exhibits no porosity. In the case of the framework structure formed by peptide 1, the greatly reduced conformational flexibility of the cyclic \u03b2-sheet peptide is sufficient to allow the formation of a well-defined assembly. The preorganized spatial arrangement of the two aspartate side chains allows the peptide to behave like a rigid ligand. Thus, a design principle emerges for the construction of other peptide-based MOFs, whereby a preference for a particular secondary structure allows preorganization of metal-binding ligands (e.g., Glu, Asp, or His).", "data": null, "include_properties": null}, {"idx": 21, "type": "text", "classification": ["else"], "content": "<p>It is important to note that larger\npeptides with well-defined secondary structures have previously been\nused with metals to construct various nanostructures. Notable examples\ninclude \u03b1-helix bundles and collagen triple helices. Many of these structures rely upon the incorporation of non-natural\nligands, most often various pyridine derivatives, into the peptide\nsequences. The three-dimensional framework formed by peptide <bold>1</bold> is distinctive, because the metal binding involves side\nchains of unmodified aspartic acid residues. We envision that it will\nbe possible to construct other large calcium-containing MOFs from\npeptides with well-defined secondary structures that display Glu or\nAsp side chains. We further envision that this design principle might\nbe extended to other metals and amino acid side chains such as His\nor Cys.</p>", "clean_text": "It is important to note that larger peptides with well-defined secondary structures have previously been used with metals to construct various nanostructures. Notable examples include \u03b1-helix bundles and collagen triple helices. Many of these structures rely upon the incorporation of non-natural ligands, most often various pyridine derivatives, into the peptide sequences. The three-dimensional framework formed by peptide 1 is distinctive, because the metal binding involves side chains of unmodified aspartic acid residues. We envision that it will be possible to construct other large calcium-containing MOFs from peptides with well-defined secondary structures that display Glu or Asp side chains. We further envision that this design principle might be extended to other metals and amino acid side chains such as His or Cys.", "data": null, "include_properties": null}, {"idx": 22, "type": "text", "classification": ["else"], "content": "<title>Conclusion</title><p>The assembly formed by peptide <bold>1</bold> in the presence of divalent metal ions constitutes a rare example\nof a metal\u2013organic framework in which a large polypeptide acts\nas a ligand. The MOF formed by peptide <bold>1</bold> is among the\nlargest peptide-based MOFs. While the structure exhibits interpenetration,\nand thus does not contain solvent-accessible pores, it demonstrates\nimportant rules for the construction of peptide-based MOFs. The peptide\u2019s\ncyclic \u03b2-sheet design exemplifies one such emergent principle,\nin which a preference for a particular secondary structure and supramolecular\nassembly allows the preorganization of metal-binding sites. We envision\nthat different peptides with well-defined secondary structures, bearing\nmultiple metal-binding residues may, in conjunction with metal ions,\nresult in MOFs. Amyloidogenic peptides are particularly suited for\nthis purpose, since they are predisposed toward supramolecular assembly.\nAmyloidogenic peptides other than medin might also serve as ligands\nfor MOF structures if they contain, or are altered to contain, suitable\nmetal-binding residues.</p>", "clean_text": "Conclusion\n\nThe assembly formed by peptide 1 in the presence of divalent metal ions constitutes a rare example of a metal-organic framework in which a large polypeptide acts as a ligand. The MOF formed by peptide 1 is among the largest peptide-based MOFs. While the structure exhibits interpenetration, and thus does not contain solvent-accessible pores, it demonstrates important rules for the construction of peptide-based MOFs. The peptide's cyclic \u03b2-sheet design exemplifies one such emergent principle, in which a preference for a particular secondary structure and supramolecular assembly allows the preorganization of metal-binding sites. We envision that different peptides with well-defined secondary structures, bearing multiple metal-binding residues may, in conjunction with metal ions, result in MOFs. Amyloidogenic peptides are particularly suited for this purpose, since they are predisposed toward supramolecular assembly. Amyloidogenic peptides other than medin might also serve as ligands for MOF structures if they contain, or are altered to contain, suitable metal-binding residues.", "data": null, "include_properties": null}, {"idx": 23, "type": "text", "classification": ["else"], "content": "<p>The Supporting Information is available free of\ncharge at <ext-link xlink:href=\"https://pubs.acs.org/doi/10.1021/jacs.0c06143?goto=supporting-info\">https://pubs.acs.org/doi/10.1021/jacs.0c06143</ext-link>.<list id=\"silist\" list-type=\"label\">\n<list-item>\n<p>Synthetic procedure, characterization\ndata (HPLC, MALDI-MS), details of X-ray crystallographic data collection,\nprocessing, and refinement for peptide <bold>1</bold>, and crystallographic\ncoordinates of peptide <bold>1</bold> were deposited into the Protein\nData Bank with PDB <ext-link ext-link-type=\"pdb\" xlink:href=\"6X4R\">6X4R</ext-link> (<ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/jacs.0c06143/suppl_file/ja0c06143_si_001.pdf\">PDF</ext-link>)</p>\n</list-item>\n<list-item>\n<p>Crystallographic\ndata for peptide <bold>1</bold> (<ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/jacs.0c06143/suppl_file/ja0c06143_si_002.cif\">CIF</ext-link>)</p>\n</list-item>\n</list>\n</p>", "clean_text": "The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/jacs.0c06143.  Synthetic procedure, characterization data (HPLC, MALDI-MS), details of X-ray crystallographic data collection, processing, and refinement for peptide 1, and crystallographic coordinates of peptide 1 were deposited into the Protein Data Bank with PDB 6X4R (PDF)   Crystallographic data for peptide 1 (CIF)   ", "data": null, "include_properties": null}, {"idx": 24, "type": "text", "classification": ["else"], "content": "<p>Synthetic procedure, characterization\ndata (HPLC, MALDI-MS), details of X-ray crystallographic data collection,\nprocessing, and refinement for peptide <bold>1</bold>, and crystallographic\ncoordinates of peptide <bold>1</bold> were deposited into the Protein\nData Bank with PDB <ext-link ext-link-type=\"pdb\" xlink:href=\"6X4R\">6X4R</ext-link> (<ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/jacs.0c06143/suppl_file/ja0c06143_si_001.pdf\">PDF</ext-link>)</p>", "clean_text": "Synthetic procedure, characterization data (HPLC, MALDI-MS), details of X-ray crystallographic data collection, processing, and refinement for peptide 1, and crystallographic coordinates of peptide 1 were deposited into the Protein Data Bank with PDB 6X4R (PDF)", "data": null, "include_properties": null}, {"idx": 25, "type": "text", "classification": ["else"], "content": "<p>Crystallographic\ndata for peptide <bold>1</bold> (<ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/jacs.0c06143/suppl_file/ja0c06143_si_002.cif\">CIF</ext-link>)</p><p>The authors declare no competing\nfinancial interest.</p>", "clean_text": "Crystallographic data for peptide 1 (CIF)\n\nThe authors declare no competing financial interest.", "data": null, "include_properties": null}], "cln_elements": [{"idx": 8, "type": "text", "classification": "synthesis condition", "content": "<p>We used X-ray crystallography to study the structure\nand assembly of peptide <bold>1</bold>. We began our crystallization\nefforts by screening peptide <bold>1</bold> in 576 conditions in a\n96-well plate format using crystallization kits from Hampton Research.\nCube-shaped crystals () grew in\nabundance in drops containing sodium acetate, calcium chloride, and\n2-methyl-2,4-pentanediol. Further optimization of the crystallization\nconditions afforded monocrystals suitable for X-ray diffraction (optimized\nconditions: 0.1 M NaOAc, 0.02 M CaCl<sub>2</sub>, 30% MPD). The X-ray\ndiffraction experiments were performed at 1.54 \u00c5 using an X-ray\ndiffractometer. Despite the relatively high resolution of the acquired\ndata set (ca. 1.32 \u00c5), we were unable to solve the structure\nby single wavelength anomalous diffraction (SAD). In an attempt to\nincrease the magnitude of anomalous scattering, we crystallized peptide <bold>1</bold> in the optimized conditions substituting barium chloride\nfor calcium chloride. The modified conditions afforded similar cube-shaped\ncrystals that gave rise to enough measurable anomalous signal to facilitate\nSAD phasing and subsequent solution of the original data set by isomorphous\nreplacement. The structure was thus solved in the cubic <italic>I</italic>23 space group and refined to a final R<sub>work</sub> of 0.1772\n(PDB <ext-link ext-link-type=\"pdb\" xlink:href=\"7JRH\">7JRH</ext-link>).</p>", "clean_text": "We used X-ray crystallography to study the structure and assembly of peptide 1. We began our crystallization efforts by screening peptide 1 in 576 conditions in a 96-well plate format using crystallization kits from Hampton Research. Cube-shaped crystals () grew in abundance in drops containing sodium acetate, calcium chloride, and 2-methyl-2,4-pentanediol. Further optimization of the crystallization conditions afforded monocrystals suitable for X-ray diffraction (optimized conditions: 0.1 M NaOAc, 0.02 M CaCl2, 30% MPD). The X-ray diffraction experiments were performed at 1.54 \u00c5 using an X-ray diffractometer. Despite the relatively high resolution of the acquired data set (ca. 1.32 \u00c5), we were unable to solve the structure by single wavelength anomalous diffraction (SAD). In an attempt to increase the magnitude of anomalous scattering, we crystallized peptide 1 in the optimized conditions substituting barium chloride for calcium chloride. The modified conditions afforded similar cube-shaped crystals that gave rise to enough measurable anomalous signal to facilitate SAD phasing and subsequent solution of the original data set by isomorphous replacement. The structure was thus solved in the cubic I23 space group and refined to a final Rwork of 0.1772 (PDB 7JRH).", "data": ["\"I do not know\"."], "include_properties": ["chemical_synthesis"]}, {"idx": 3, "type": "table", "classification": ["Property"], "content": "<table-wrap id=\"tbl1\" position=\"float\">\n<label>1</label>\n<caption>\n<title>Supramolecular Assemblies of Selected Sequences Derived\nfrom Amyloidogenic Peptides and Proteins</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"4\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col3\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col4\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\">peptide</oasis:entry>\n<oasis:entry align=\"center\">sequence</oasis:entry>\n<oasis:entry align=\"center\">assembly</oasis:entry>\n<oasis:entry align=\"center\">citation</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>A\u03b2(10\u201335)</oasis:entry>\n<oasis:entry>YEV\u00adHHQ\u00adKLV\u00adFFA\u00adEDV\u00adGSN\u00adKGA\u00adIIG\u00adLM</oasis:entry>\n<oasis:entry>fibril<xref ref-type=\"table-fn\" rid=\"t1fn1\"></xref>\n<sup>,</sup>\n<xref ref-type=\"table-fn\" rid=\"t1fn2\"></xref>\n</oasis:entry>\n<oasis:entry>\n<named-content content-type=\"bibref-group\">\n<xref ref-type=\"bibr\" rid=\"ref1\" specific-use=\"ref-style=base-text\"></xref>\u2212<xref ref-type=\"bibr\" rid=\"ref2\" specific-use=\"suppress-in-print\"></xref>\n<xref ref-type=\"bibr\" rid=\"ref3\" specific-use=\"ref-style=base-text\"></xref>\n</named-content>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>A\u03b2(16\u201322)</oasis:entry>\n<oasis:entry>Ac-KLVFFAE-NH2</oasis:entry>\n<oasis:entry>fibril, helical ribbon, nanotube<xref ref-type=\"table-fn\" rid=\"t1fn1\"></xref>\n<sup>,</sup>\n<xref ref-type=\"table-fn\" rid=\"t1fn2\"></xref>\n<sup>,</sup>\n<xref ref-type=\"table-fn\" rid=\"t1fn3\"></xref>\n<sup>,</sup>\n<xref ref-type=\"table-fn\" rid=\"t1fn4\"></xref>\n</oasis:entry>\n<oasis:entry>\n<named-content content-type=\"bibref-group\">\n<xref ref-type=\"bibr\" rid=\"ref4\" specific-use=\"ref-style=base-text\"></xref>\u2212<xref ref-type=\"bibr\" rid=\"ref5\" specific-use=\"suppress-in-print\"></xref>\n<xref ref-type=\"bibr\" rid=\"ref6\" specific-use=\"ref-style=base-text\"></xref>\n</named-content>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry></oasis:entry>\n<oasis:entry>KLVF(<italic>N</italic>-Me)FAE,\nKLVFFAE</oasis:entry>\n<oasis:entry>nanotube<xref ref-type=\"table-fn\" rid=\"t1fn5\"></xref>\n</oasis:entry>\n<oasis:entry>\n<xref ref-type=\"bibr\" rid=\"ref7\" specific-use=\"ref-style=base-text\"></xref>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>A\u03b2(16\u201322), Italian mutant</oasis:entry>\n<oasis:entry>KLVFFAK</oasis:entry>\n<oasis:entry>nanosheet<xref ref-type=\"table-fn\" rid=\"t1fn2\"></xref>\n<sup>,</sup>\n<xref ref-type=\"table-fn\" rid=\"t1fn3\"></xref>\n</oasis:entry>\n<oasis:entry>\n<xref ref-type=\"bibr\" rid=\"ref8\" specific-use=\"ref-style=base-text\"></xref>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry morerows=\"1\">A\u03b2(16\u201320)</oasis:entry>\n<oasis:entry>AAKLVFF</oasis:entry>\n<oasis:entry>nanotube<xref ref-type=\"table-fn\" rid=\"t1fn2\"></xref>\n</oasis:entry>\n<oasis:entry>\n<named-content content-type=\"bibref-group\">\n<xref ref-type=\"bibr\" rid=\"ref9\" specific-use=\"ref-style=base-text\"></xref>,<xref ref-type=\"bibr\" rid=\"ref10\" specific-use=\"ref-style=base-text\"></xref>\n</named-content>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b2A\u03b2AKLVFF</oasis:entry>\n<oasis:entry>helical ribbon<xref ref-type=\"table-fn\" rid=\"t1fn4\"></xref>\n</oasis:entry>\n<oasis:entry>\n<xref ref-type=\"bibr\" rid=\"ref11\" specific-use=\"ref-style=base-text\"></xref>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>A\u03b2(19\u201320)</oasis:entry>\n<oasis:entry>FF</oasis:entry>\n<oasis:entry>nanotube<xref ref-type=\"table-fn\" rid=\"t1fn2\"></xref>\n</oasis:entry>\n<oasis:entry>\n<xref ref-type=\"bibr\" rid=\"ref12\" specific-use=\"ref-style=base-text\"></xref>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry></oasis:entry>\n<oasis:entry>Ac-FF-NH<sub>2</sub>, NH<sub>2</sub>-FF-NH<sub>2</sub>, Boc-FF-NH2</oasis:entry>\n<oasis:entry>nanotube<xref ref-type=\"table-fn\" rid=\"t1fn2\"></xref>\n<sup>,</sup>\n<xref ref-type=\"table-fn\" rid=\"t1fn3\"></xref>\n</oasis:entry>\n<oasis:entry>\n<xref ref-type=\"bibr\" rid=\"ref13\" specific-use=\"ref-style=base-text\"></xref>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry></oasis:entry>\n<oasis:entry>Fmoc-FF</oasis:entry>\n<oasis:entry>flat ribbon, fibril<xref ref-type=\"table-fn\" rid=\"t1fn2\"></xref>\n<sup>,</sup>\n<xref ref-type=\"table-fn\" rid=\"t1fn3\"></xref>\n<sup>,</sup>\n<xref ref-type=\"table-fn\" rid=\"t1fn4\"></xref>\n</oasis:entry>\n<oasis:entry>\n<named-content content-type=\"bibref-group\">\n<xref ref-type=\"bibr\" rid=\"ref13\" specific-use=\"ref-style=base-text\"></xref>,<xref ref-type=\"bibr\" rid=\"ref14\" specific-use=\"ref-style=base-text\"></xref>\n</named-content>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>hIAPP(20\u201329)</oasis:entry>\n<oasis:entry>SNNFGAILSS</oasis:entry>\n<oasis:entry>flat ribbon, helical ribbon<xref ref-type=\"table-fn\" rid=\"t1fn3\"></xref>\n<sup>,</sup>\n<xref ref-type=\"table-fn\" rid=\"t1fn4\"></xref>\n</oasis:entry>\n<oasis:entry>\n<xref ref-type=\"bibr\" rid=\"ref15\" specific-use=\"ref-style=base-text\"></xref>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry></oasis:entry>\n<oasis:entry>SNNFG(<italic>N</italic>-Bu)AI(<italic>N</italic>-Bu)LS(<italic>N</italic>-Bu)S</oasis:entry>\n<oasis:entry>helical ribbon<xref ref-type=\"table-fn\" rid=\"t1fn2\"></xref>\n</oasis:entry>\n<oasis:entry>\n<xref ref-type=\"bibr\" rid=\"ref16\" specific-use=\"ref-style=base-text\"></xref>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>hIAPP(21\u201329)</oasis:entry>\n<oasis:entry>NNFGAILSS</oasis:entry>\n<oasis:entry>helical ribbon<xref ref-type=\"table-fn\" rid=\"t1fn2\"></xref>\n<sup>,</sup>\n<xref ref-type=\"table-fn\" rid=\"t1fn3\"></xref>\n</oasis:entry>\n<oasis:entry>\n<xref ref-type=\"bibr\" rid=\"ref17\" specific-use=\"ref-style=base-text\"></xref>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>hIAPP(23\u201327)</oasis:entry>\n<oasis:entry>FGAIL</oasis:entry>\n<oasis:entry>flat ribbon<xref ref-type=\"table-fn\" rid=\"t1fn2\"></xref>\n<sup>,</sup>\n<xref ref-type=\"table-fn\" rid=\"t1fn3\"></xref>\n</oasis:entry>\n<oasis:entry>\n<xref ref-type=\"bibr\" rid=\"ref18\" specific-use=\"ref-style=base-text\"></xref>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>tau(306-311)</oasis:entry>\n<oasis:entry>Ac-VQIVYK-NH<sub>2</sub>\n</oasis:entry>\n<oasis:entry>straight and twisted\nfilament<xref ref-type=\"table-fn\" rid=\"t1fn2\"></xref>\n</oasis:entry>\n<oasis:entry>\n<xref ref-type=\"bibr\" rid=\"ref19\" specific-use=\"ref-style=base-text\"></xref>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>transthyretin(106\u2013112, 115\u2013121)</oasis:entry>\n<oasis:entry>TIAA(<italic>N</italic>-Me)LLS, SFSTTAV</oasis:entry>\n<oasis:entry>square channel<xref ref-type=\"table-fn\" rid=\"t1fn5\"></xref>\n</oasis:entry>\n<oasis:entry>\n<xref ref-type=\"bibr\" rid=\"ref20\" specific-use=\"ref-style=base-text\"></xref>\n</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b1B-crystallin(90\u2013100)</oasis:entry>\n<oasis:entry>KVK\u00adVLG\u00adDVI\u00adEV</oasis:entry>\n<oasis:entry>cylindrin<xref ref-type=\"table-fn\" rid=\"t1fn2\"></xref>\n<sup>,</sup>\n<xref ref-type=\"table-fn\" rid=\"t1fn5\"></xref>\n</oasis:entry>\n<oasis:entry>\n<xref ref-type=\"bibr\" rid=\"ref21\" specific-use=\"ref-style=base-text\"></xref>\n</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n<table-wrap-foot>\n<fn id=\"t1fn1\">\n<label>a</label>\n<p>Solid-state NMR (ssNMR).</p>\n</fn>\n<fn id=\"t1fn2\">\n<label>b</label>\n<p>Electron microscopy (EM).</p>\n</fn>\n<fn id=\"t1fn3\">\n<label>c</label>\n<p>Atomic force microscopy (AFM).</p>\n</fn>\n<fn id=\"t1fn4\">\n<label>d</label>\n<p>Cryo-EM.</p>\n</fn>\n<fn id=\"t1fn5\">\n<label>e</label>\n<p>X-ray crystallography.</p>\n</fn>\n</table-wrap-foot>\n</table-wrap>", "clean_text": "Table 1. Supramolecular Assemblies of Selected Sequences Derived from Amyloidogenic Peptides and Proteins\n\n| peptide | sequence | assembly | citation |\n|---------|----------|----------|----------|\n| A\u03b2(10\u201335) | YEV\u00adHHQ\u00adKLV\u00adFFA\u00adEDV\u00adGSN\u00adKGA\u00adIIG\u00adLM | fibril[^a][^b] | [^1]\u2212[^3] |\n| A\u03b2(16\u201322) | Ac-KLVFFAE-NH2 | fibril, helical ribbon, nanotube[^a][^b][^c][^d] | [^4]\u2212[^6] |\n| | KLVF(N-Me)FAE, KLVFFAE | nanotube[^e] | [^7] |\n| A\u03b2(16\u201322), Italian mutant | KLVFFAK | nanosheet[^b][^c] | [^8] |\n| A\u03b2(16\u201320) | AAKLVFF | nanotube[^b] | [^9],[^10] |\n| \u03b2A\u03b2AKLVFF | | helical ribbon[^c] | [^11] |\n| A\u03b2(19\u201320) | FF | nanotube[^b] | [^12] |\n| | Ac-FF-NH<sub>2</sub>, NH<sub>2</sub>-FF-NH<sub>2</sub>, Boc-FF-NH2 | nanotube[^b][^c] | [^13] |\n| | Fmoc-FF | flat ribbon, fibril[^b][^c][^d] | [^13],[^14] |\n| hIAPP(20\u201329) | SNNFGAILSS | flat ribbon, helical ribbon[^c][^d] | [^15] |\n| | SNNFG(N-Bu)AI(N-Bu)LS(N-Bu)S | helical ribbon[^b] | [^16] |\n| hIAPP(21\u201329) | NNFGAILSS | helical ribbon[^b][^c] | [^17] |\n| hIAPP(23\u201327) | FGAIL | flat ribbon[^b][^c] | [^18] |\n| tau(306-311) | Ac-VQIVYK-NH<sub>2</sub> | straight and twisted filament[^b] | [^19] |\n| transthyretin(106\u2013112, 115\u2013121) | TIAA(N-Me)LLS, SFSTTAV | square channel[^e] | [^20] |\n| \u03b1B-crystallin(90\u2013100) | KVK\u00adVLG\u00adDVI\u00adEV | cylindrin[^b][^e] | [^21] |\n\n[^a]: Solid-state NMR (ssNMR).\n[^b]: Electron microscopy (EM).\n[^c]: Atomic force microscopy (AFM).\n[^d]: Cryo-EM.\n[^e]: X-ray crystallography.", "data": [{"meta": {"name": "A\u03b2(10\u201335)", "symbol": "", "chemical formula": "YEV\u00adHHQ\u00adKLV\u00adFFA\u00adEDV\u00adGSN\u00adKGA\u00adIIG\u00adLM"}, "assembly": [{"value": "fibril", "condition": "Solid-state NMR (ssNMR), Electron microscopy (EM)"}]}, {"meta": {"name": "A\u03b2(16\u201322)", "symbol": "", "chemical formula": "Ac-KLVFFAE-NH2"}, "assembly": [{"value": "fibril", "condition": "Solid-state NMR (ssNMR), Electron microscopy (EM), Atomic force microscopy (AFM), Cryo-EM"}, {"value": "helical ribbon", "condition": "Solid-state NMR (ssNMR), Electron microscopy (EM), Atomic force microscopy (AFM), Cryo-EM"}, {"value": "nanotube", "condition": "Solid-state NMR (ssNMR), Electron microscopy (EM), Atomic force microscopy (AFM), Cryo-EM"}]}, {"meta": {"name": "A\u03b2(16\u201322), Italian mutant", "symbol": "", "chemical formula": "KLVFFAK"}, "assembly": [{"value": "nanosheet", "condition": "Electron microscopy (EM), Atomic force microscopy (AFM)"}]}, {"meta": {"name": "A\u03b2(19\u201320)", "symbol": "", "chemical formula": "FF"}, "assembly": [{"value": "nanotube", "condition": "Electron microscopy (EM)"}]}, {"meta": {"name": "hIAPP(20\u201329)", "symbol": "", "chemical formula": "SNNFGAILSS"}, "assembly": [{"value": "flat ribbon", "condition": "Atomic force microscopy (AFM), Cryo-EM"}, {"value": "helical ribbon", "condition": "Atomic force microscopy (AFM), Cryo-EM"}]}, {"meta": {"name": "hIAPP(23\u201327)", "symbol": "", "chemical formula": "FGAIL"}, "assembly": [{"value": "flat ribbon", "condition": "Electron microscopy (EM), Atomic force microscopy (AFM)"}]}, {"meta": {"name": "tau(306-311)", "symbol": "", "chemical formula": "Ac-VQIVYK-NH2"}, "assembly": [{"value": "straight and twisted filament", "condition": "Electron microscopy (EM)"}]}, {"meta": {"name": "\u03b1B-crystallin(90\u2013100)", "symbol": "", "chemical formula": "KVK\u00adVLG\u00adDVI\u00adEV"}, "assembly": [{"value": "cylindrin", "condition": "Electron microscopy (EM), X-ray crystallography"}]}], "include_properties": ["topology"]}, {"idx": 5, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig1\" position=\"float\">\n<label>1</label>\n<caption>\n<p>Amino acid\nsequence of medin. Amyloidogenic regions predicted by TANGO are highlighted\nin red. Underlined residues are \u03b2-strand regions identified\nby <sup>13</sup>C NMR spectroscopy.</p>\n</caption>\n<graphic id=\"gr1\" position=\"float\" xlink:href=\"ja0c06143_0001.tif\"></graphic>\n</fig>", "clean_text": " 1  Amino acid sequence of medin. Amyloidogenic regions predicted by TANGO are highlighted in red. Underlined residues are \u03b2-strand regions identified by 13C NMR spectroscopy.   ", "data": null, "include_properties": null}, {"idx": 10, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig2\" position=\"float\">\n<label>2</label>\n<caption>\n<p>Three-dimensional assembly observed in the X-ray crystallographic\nstructure of peptide <bold>1</bold>. Individual cube (A), infinite\narray of cubes (C), and two interpenetrating arrays (E), along with\ntheir respective schematic representations (B, D, and F). The cubes\nare all symmetry-equivalent, and the coloring scheme has been chosen\narbitrarily for clarity.</p>\n</caption>\n<graphic id=\"gr3\" position=\"float\" xlink:href=\"ja0c06143_0002.tif\"></graphic>\n</fig>", "clean_text": " 2  Three-dimensional assembly observed in the X-ray crystallographic structure of peptide 1. Individual cube (A), infinite array of cubes (C), and two interpenetrating arrays (E), along with their respective schematic representations (B, D, and F). The cubes are all symmetry-equivalent, and the coloring scheme has been chosen arbitrarily for clarity.   ", "data": null, "include_properties": null}, {"idx": 13, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig3\" position=\"float\">\n<label>3</label>\n<caption>\n<p>(A) The location of a\ntetramer within the cubic assembly of peptide <bold>1</bold>. (B)\nHydrogen-bonded dimer within the tetramer.</p>\n</caption>\n<graphic id=\"gr4\" position=\"float\" xlink:href=\"ja0c06143_0003.tif\"></graphic>\n</fig>", "clean_text": " 3  (A) The location of a tetramer within the cubic assembly of peptide 1. (B) Hydrogen-bonded dimer within the tetramer.   ", "data": null, "include_properties": null}, {"idx": 15, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig4\" position=\"float\">\n<label>4</label>\n<caption>\n<p>\u03b2-Bulge\nin the X-ray crystallographic structure of peptide <bold>1</bold>.\n(A) X-ray crystallographic structure of the monomeric \u03b2-hairpin\nsubunit of the crystal lattice. (B) Hydrogen bonding pattern observed\nin the X-ray structure.</p>\n</caption>\n<graphic id=\"gr5\" position=\"float\" xlink:href=\"ja0c06143_0004.tif\"></graphic>\n</fig>", "clean_text": " 4  \u03b2-Bulge in the X-ray crystallographic structure of peptide 1. (A) X-ray crystallographic structure of the monomeric \u03b2-hairpin subunit of the crystal lattice. (B) Hydrogen bonding pattern observed in the X-ray structure.   ", "data": null, "include_properties": null}, {"idx": 17, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig5\" position=\"float\">\n<label>5</label>\n<caption>\n<p>(A and B) Calcium binding geometry observed in the X-ray\ncrystallographic structure of peptide <bold>1</bold>. (C) Calcium\nbinding site in the calmodulin protein (PDB <ext-link ext-link-type=\"pdb\" xlink:href=\"1CLL\">1CLL</ext-link>). Calcium ions are\nshown as yellow spheres and water molecules as red spheres.</p>\n</caption>\n<graphic id=\"gr6\" position=\"float\" xlink:href=\"ja0c06143_0005.tif\"></graphic>\n</fig>", "clean_text": " 5  (A and B) Calcium binding geometry observed in the X-ray crystallographic structure of peptide 1. (C) Calcium binding site in the calmodulin protein (PDB 1CLL). Calcium ions are shown as yellow spheres and water molecules as red spheres.   ", "data": null, "include_properties": null}], "metadata": {"doi": "10.1021/jacs.0c06143", "title": "\nInterpenetrating\nCubes in the X\u2011ray Crystallographic Structure of a Peptide\nDerived from Medin19\u201336\n\n", "journal": "American Chemical\nSociety", "date": "2020.08", "author_list": ["Howitz\nWilliam J.", "Wierzbicki\nMicha\u0142", "Cabanela\nRudy William", "Saliba\nCindy", "Motavalli\nAriana", "Tran\nNgoctran", "Nowick\nJames S."]}}